Search | OpenScholar

Search results

193 results found

Long-term effects of rasagiline and the natural history of treated Parkinson's disease. Mov Disord 2016;31:1489-1496.

Publication: Journal Article

Rascol, O, RA Hauser, F Stocchi, CJ Fitzer-Attas, Y Sidi, V Abler, CW Olanow, and AFU Investigators. 2016. “Long-Term Effects of Rasagiline and the Natural History of Treated Parkinson’s Disease. Mov Disord 2016;31:1489-1496.”. Mov Disord.

Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson's Disease and Dyskinesia. Neurol Ther. 2021 Dec;10(2):739-751. doi: 10.1007/s40120-021-00256-1.

Publication: Journal Article

Hauser, RA, SH Mehta, D Kremens, D Chernick, and AE Formella. 2021. “Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People With Parkinson’s Disease and Dyskinesia. Neurol Ther. 2021 Dec;10(2):739-751. Doi: 10.1007/S40120-021-00256-1.”. Neurol Ther.

Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3). Mov Disord 2017;32:1701-1709.

Publication: Journal Article

Oertel, W, K Eggert, R Pahwa, CM Tanner, RA Hauser, C Trenkwalder, R Ehret, et al. 2017. “Randomized, Placebo-Controlled Trial of ADS-5102 (amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASE LID 3). Mov Disord 2017;32:1701-1709.”. Mov Disord.

CD 140 Study Group. Efficacy, tolerability, and immunogenicity of onabotulinumtoxina in a randomized, double-blind, placebo-controlled trial for cervical dystonia. Clin Neuropharmacol 2012;35:208-14.

Publication: Journal Article

Charles, D, A Brashear, RA Hauser, Li HI, LM Boo, and MF Brin. 2012. “CD 140 Study Group. Efficacy, Tolerability, and Immunogenicity of Onabotulinumtoxina in a Randomized, Double-Blind, Placebo-Controlled Trial for Cervical Dystonia. Clin Neuropharmacol 2012;35:208-14.”. Clin Neuropharmacol.

Randomized clinical trial of fipamezole for dyskinesia in Parkinson disease (FJORD study). Neurology 2012;79:163-9.

Publication: Journal Article

LeWitt, PA, RA Hauser, M Lu, AP Nicholas, W Weiner, N Coppard, M Leinonen, and JM Savola. 2012. “Randomized Clinical Trial of Fipamezole for Dyskinesia in Parkinson Disease (FJORD Study). Neurology 2012;79:163-9.”. Neurology.

A(2A) Receptor Antagonism and Dyskinesia in Parkinson's Disease. Parkinsons Dis 2012;1-8.

Publication: Journal Article

Morelli, M, F Blandini, N Simola, and RA Hauser. 2012. “A(2A) Receptor Antagonism and Dyskinesia in Parkinson’s Disease. Parkinsons Dis 2012;1-8.”. Parkinsons Dis.

Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial. Lancet Neurol 2011;10:221-9.

Publication: Journal Article

Hauser, RA, M Cantillon, E Pourcher, F Micheli, V Mok, M Onofrj, S Huyck, and K Wolski. 2011. “Preladenant in Patients With Parkinson’s Disease and Motor Fluctuations: A Phase 2, Double-Blind, Randomised Trial. Lancet Neurol 2011;10:221-9.”. Lancet Neurol.

Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's disease. Mov Disord 2014;29:1028-34.

Publication: Journal Article

Hauser, RA, D Silver, A Choudhry, E Eyal, and S Isaacson. 2014. “Randomized, Controlled Trial of Rasagiline As an Add-on to Dopamine Agonists in Parkinson’s Disease. Mov Disord 2014;29:1028-34.”. Mov Disord.

Spine Simulator for Advancing Spine-Related Research

Blog: October 22, 2024

The NeuBaC Research Lab is leading cutting-edge research into spinal biomechanics with a focus on developing innovative solutions for spinal injuries and degeneration. Utilizing a patented cadaveric 6-axis spine simulator, the lab can assess the effects of surgical interventions, implants, and...

A Systematic Review of Dietary Influences on Fecal Microbiota Composition and Function among Healthy Humans 1-20 Years of Age.

Publication: Journal Article

Dinsmoor, Andrew M, Miriam Aguilar-Lopez, Naiman A Khan, and Sharon M Donovan. 2021. “A Systematic Review of Dietary Influences on Fecal Microbiota Composition and Function Among Healthy Humans 1-20 Years of Age.”. Advances in Nutrition (Bethesda, Md.) 12 (5): 1734-50.